Seeking Alpha

Atanas Matov's  Instablog

Atanas Matov
Send Message
Successfully meeting the challenge of conceptualizing ideas and turning visions into viable and productive organizations has been the focal point of my initiations. Being President of Anglia Ruskin Investment Society (ARIS) and Fund Manager of its Long Term Fund, my aim is to continue growing... More
My company:
ARIS
  • HOT HEALTHCARE STOCKS FOR JANUARY-FEBRUARY 2011 0 comments
    Jan 12, 2011 8:11 PM | about stocks: BEAT, IDIX, APRI, BVX, AVNR
    There are 5 hot stocks that have caught my attention recently. Аs a technical analyst myself and an active trader I have listed several healthcare stocks that have great potential for extreme returns over the next one-two months. The charts below describe the entry point, stop-loss and target areas.


    The first stock is: CardioNet Inc (NASDAQ:BEAT)

    Source: Stockcharts.com

    The entry level is $4.96 and our initial target is $6.00. This comes to approximately 21%. The stop-loss is put on the level of $4.6, which is about 8%. The secondary price target is around the $8 area. If $8 level is reached, this means a return of 61%.


    The rest of the stocks are listed below as follows:

    Idenix Pharmaceuticals (NASDAQ:IDIX)

    Source: Stockcharts.com


    The entry level is $5.14 and our initial target is $6.00. This comes to approximately 17%. The stop-loss is put just below the level of $4.9, which is about 5%. The secondary price target is around the $7-8 area. If $8 level is reached, this means a return of 55%.

    Apricus Biosciences Inc (NASDAQ:APRI)
    Source: Stockcharts.com

    The entry level is $3.69 and our initial target is $6.00. This comes to approximately 63%. The stop-loss is put just below the level of $3.11, which is about 19 per cent. The secondary price target is around the $8-10 area. If $10 level is reached, this means a return of 271%.


    Bovie Medical Corp (NYSEMKT:BVX
    Source: Stockcharts.com

    The entry level is $3.31 and our initial target is $5.00. This comes to approximately 51%. The stop-loss is put just below the level of $3.00, which is about 10 per cent. The secondary price target is around the $7.5-8 area. If $8 level is reached, this means a return of 242%.


    Anavir Pharmaceuticals (NASDAQ:AVNR)

    Source: Stockcharts.com

    The entry level is $4.45 and our initial target is $5.75. This comes to approximately 30%. The stop-loss is put just below the level of $4.00, which is about 11 per cent. The secondary price target is around the $7.5-8 area. If $8 level is reached, this means a return of 180%.


    Disclosure: I am long APRI, AVNR.
    Stocks: BEAT, IDIX, APRI, BVX, AVNR
Back To Atanas Matov's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

Latest Comments


Most Commented
  1. Four Stocks Going Up (1 Comment)
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.